Depletion of mitochondrial DNA in HIV‐1‐infected patients and its amelioration by antiretroviral therapy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Medical Virology

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jmv.10423PMID 12794710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy.

  2002cited by this paper
• Analysis of the mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with or without lipoatrophy

  2002cited by this paper
• Productive HIV-1 Infection of Primary CD4+ T Cells Induces Mitochondrial Membrane Permeabilization Leading to a Caspase-independent Cell Death*

  2002cited by this paper
• Mitochondrial functionality and mitochondrial DNA content in lymphocytes of vertically infected human immunodeficiency virus-positive children with highly active antiretroviral therapy-related lipodystrophy.

  2002cited by this paper
• Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients.

  2002cited by this paper
• Mitochondrial DNA in aging and degenerative disease.

  2001cited by this paper
• Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss.

  2001cited by this paper
• Binding of Human Immunodeficiency Virus Type 1 gp120 to CXCR4 Induces Mitochondrial Transmembrane Depolarization and Cytochromec-Mediated Apoptosis Independently of Fas Signaling

  2001cited by this paper
• Clinical assessment of HIV-associated lipodystrophy in an ambulatory population

  2001cited by this paper
• Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?

  2001cited by this paper
• Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy

  2001cited by this paper
• Mitochondrial involvement in antiretroviral therapy-related lipodystrophy

  2001cited by this paper
• Mitochondrial toxicity and HIV therapy

  2001cited by this paper
• Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

  2001cited by this paper
• Differential Incorporation and Removal of Antiviral Deoxynucleotides by Human DNA Polymerase γ*

  2001cited by this paper
• Apoptosis Enhancement by the HIV-1 Nef Protein1

  2001cited by this paper
• The prevalence of lipodystrophy in an ambulant HIV‐infected population: it all depends on the definition

  2001cited by this paper
• Mitochondrial Control of Cell Death Induced by HIV‐1‐Encoded Proteins

  2000cited by this paper
• Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

  2000cited by this paper
• Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity.

  2000cited by this paper
• Apoptosis Control in Syncytia Induced by the HIV Type 1–Envelope Glycoprotein Complex

  2000cited by this paper
• Apoptosis and apoptosis‐associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long‐term non‐progressors

  2000cited by this paper
• The HIV-1 Viral Protein R Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore

  2000cited by this paper
• Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

  1999cited by this paper
• The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy.

  1999cited by this paper
• Susceptibility of HIV-1-TAT transfected cells to undergo apoptosis. Biochemical mechanisms

  1999cited by this paper
• A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

  1999cited by this paper
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy.

  1999cited by this paper
• Clinical, histological and molecular reversibility of zidovudine myopathy.

  1998cited by this paper
• Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome

  1997cited by this paper
• Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.

  1997cited by this paper
• Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy.

  1997cited by this paper
• The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction.

  1996cited by this paper
• Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers.

  1995cited by this paper
• Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

  1994cited by this paper
• Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

  1994cited by this paper
• Mitochondrial DNA Synthesis

  1993cited by this paper
• Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy.

  1991cited by this paper
• Comparison of Mitochondrial Morphology, Mitochondrial DNA

  year unknowncited by this paper

• Evidence of Greater Immune Aging among Untreated HIV Slow Progressors than Antiretroviral-controlled People Living with HIV.

  2025cites this paper
• Mitochondrial DNA in cell death and inflammation

  2023cites this paper
• HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles

  2023influential citation
• Ageing with HIV: Challenges and biomarkers

  2022cites this paper
• Long-term treated HIV infection is associated with platelet mitochondrial dysfunction

  2021cites this paper
• Mitochondrial DNA damage and brain ageing in HIV.

  2020cites this paper
• HIV-1 and HIV-1-Tat Induce Mitochondrial DNA Damage in Human Neurons

  2020cites this paper
• Mitochondrial DNA Damage and Brain Aging in Human Immunodeficiency Virus

  2020cites this paper
• The determination of human peripheral blood mononuclear cell counts using a genomic DNA standard and application in tenofovir diphosphate quantitation.

  2019cites this paper
• HIV-Associated NAFLD: Disease Burden and Management

  2019cites this paper
• Association Between HIV Infection and Mitochondrial DNA Copy Number in Peripheral Blood: A Population-Based, Prospective Cohort Study

  2018cites this paper
• Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients

  2018cites this paper
• Quantitation of intracellular triphosphate metabolites of antiretroviral agents in peripheral blood mononuclear cells (PBMCs) and corresponding cell count determinations: review of current methods and challenges

  2018cites this paper
• A Monochrome Multiplex Real-Time Quantitative PCR Assay for the Measurement of Mitochondrial DNA Content.

  2018cites this paper
• Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.

  2017cites this paper
• Adipose Tissue in HIV Infection.

  2017cites this paper
• Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy.

  2017cites this paper
• Distinct Mitochondrial Disturbance in CD4+T and CD8+T Cells From HIV-Infected Patients

  2017cites this paper
• Plasma mitochondrial DNA levels are inversely associated with HIV-RNA levels and directly with CD4 counts: potential role as a biomarker of HIV replication

  2017cites this paper
• Recent advancements in diagnostic tools in mitochondrial energy metabolism diseases.

  2016cites this paper
• Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

  2016cites this paper
• Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.

  2013cites this paper
• HIV-1 Infection Is Blocked at an Early Stage in Cells Devoid of Mitochondrial DNA

  2013cites this paper
• Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV-Infected Children in Accra

  2013cites this paper
• The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy.

  2013cites this paper
• Impact of the DNA extraction method on 2-LTR DNA circle recovery from HIV-1 infected cells.

  2013cites this paper
• Antiretroviral Nucleoside Analogues Suppress Antibody Synthesis in Human B-Lymphocytes

  2012cites this paper
• Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial DNA Levels in Placenta and Umbilical Cords

  2012cites this paper
• HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue.

  2012cites this paper
• High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells

  2012cites this paper
• T Cell Activation Markers and African Mitochondrial DNA Haplogroups among Non-Hispanic Black Participants in AIDS Clinical Trials Group Study 384

  2012cites this paper
• Human immunodeficiency virus and its effects on the visual system

  2012cites this paper
• Mechanisms of AIDS-related lymphoma pathogenesis

  2012cites this paper
• Mitochondrial functionalism in HIV-infected children receiving antiretroviral therapy

  2012cites this paper
• Mitochondrial dysfunction and human immunodeficiency virus infection

  2011cites this paper
• Mitochondrial dysfunction and human immunodeficiency virus infection

  2011cites this paper
• Non-Nucleoside Reverse Transcriptase Inhibitors Efavirenz and Nevirapine Inhibit Cytochrome C Oxidase in Mouse Brain Regions

  2011cites this paper
• Genetic Variants in Nuclear-Encoded Mitochondrial Genes Influence AIDS Progression

  2010cites this paper
• Evolution of Mitochondrial DNA Content After Planned Interruption of HAART in HIV-Infected Pediatric Patients

  2010cites this paper
• Mitochondrial Haplogroups Are Associated With Risk of Neuroretinal Disorder in HIV-Positive Patients

  2010cites this paper
• Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients

  2010cites this paper
• The Role of Mitochondria in HIV Infection and Its Treatment

  2010cites this paper
• Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?

  2009influential citation
• Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

  2009cites this paper
• Antiretroviral Exposure and Lymphocyte mtDNA Content Among Uninfected Infants of HIV-1-Infected Women

  2009cites this paper
• Mitochondrial DNA haplogroups influence AIDS progression

  2008cites this paper
• Mecanismes fisiopatològics de lesió mitocondrial secundària: antiretrovirals, antibiòtics, antipsicòtics i monòxid de carboni.

  2008cites this paper
• Einfluss der HIV-Infektion und der antiretroviralen Therapie auf das mitochondriale Membranpotential von peripheren mononukleären Blutzellen

  2008cites this paper
• Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.

  2008cites this paper
• Untersuchung des mitochondrialen Membranpotentials und der Apoptoserate peripherer mononukleärer Blutzellen HIV-positiver, bisher nicht antiretroviral behandelter Patienten

  2008cites this paper
• Mitochondrial RNA and DNA alterations in HIV lipoatrophy are linked to antiretroviral therapy and not to HIV infection

  2008cites this paper
• Mitochondrial Disorders among Infants Exposed to HIV and Antiretroviral Therapy

  2007cites this paper
• Mitochondrial toxicity of HIV-1 infection and its treatment

  2007cites this paper
• Mitochondrial DNA depletion in HIV-infected patients with chronic hepatitis C and effect of pegylated interferon plus ribavirin therapy

  2007cites this paper
• The Influence of HIV Infection and Antiretroviral Therapy on the Mitochondrial Membrane Potential of Peripheral Mononuclear Cells

  2007cites this paper
• Toxicogenetics of Antiretroviral Therapy: Genetic Factors that Contribute to Metabolic Complications

  2007cites this paper
• Oxidative stress in NRTI-induced toxicity

  2007cites this paper
• Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV‐infected patients with lipodystrophy according to a validated case definition

  2007cites this paper
• HIV neuropathy natural history cohort study

  2006cites this paper
• Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients

  2006cites this paper
• Reduced Aerobic Capacity and Physical Functioning in Older HIV-Infected Men

  2006cites this paper
• Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV‐1‐infected treatment‐naïve patients

  2006cites this paper
• Adverse Effects of Antiretroviral Drugs on HIV-1-Infected and -Uninfected Human Monocyte-Derived Macrophages

  2006cites this paper
• Mitochondrial AZT metabolism

  2006cites this paper
• Toxic metabolic syndrome associated with HAART

  2006cites this paper
• Pulsatile tinnitus from a redundant arterial loop

  2006cites this paper
• Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy.

  2006cites this paper
• Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics

  2005cites this paper
• The Role of Hepatitis C Virus (HCV) in Mitochondrial Dna Damage in HIV/HCV-Coinfected Individuals

  2005cites this paper
• Possible Ways Nucleoside Analogues Can Affect Mitochondrial Dna Content and Gene Expression during HIV Therapy

  2005cites this paper
• [Mitochondrial hepatic toxicity associated with antiretroviral treatment].

  2005cites this paper
• In Vivo Effects of Highly Active Antiretroviral Therapies Containing the Protease Inhibitor Nelfinavir on Mitochondrially Driven Apoptosis

  2005cites this paper
• Fetal and neonatal exposure to AZT and low-protein diet affects glucose homeostasis: a model with implications for AIDS prevention.

  2005cites this paper
• Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

  2005cites this paper
• In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA.

  2005cites this paper
• Pathogenic mechanisms of mitochondrial DNA depletion in patients with HIV-1 infection.

  2005cites this paper
• Nucleoside Reverse Transcriptase Inhibitors, Mitochondrial Dna and Aids Therapy

  2005cites this paper
• Infection with HIV-1 induces a decrease in mtDNA.

  2005cites this paper
• Extensive Investigations of Mitochondrial DNA Genome in Treated HIV-Infected Subjects: Beyond Mitochondrial DNA Depletion

  2005cites this paper
• Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.

  2005cites this paper
• Is the recent emergence of community-associated methicillin-resistant Staphylococcus aureus among participants in competitive sports limited to participants?

  2005cites this paper
• Mitochondrial Dna Depletion in HIV-Infected Patients is More Pronounced with Chronic Hepatitis C and Enhanced following Treatment with Pegylated Interferon plus Ribavirin

  2005cites this paper
• Mitochondrial Dna Levels of Peripheral Blood Mononuclear Cells and Subcutaneous Adipose Tissue from Thigh, Fat and Abdomen of HIV-1 Seropositive and Negative Individuals

  2005cites this paper
• Mitochondrial (Mt)Dna Changes in Tissue May Not be Reflected by Depletion of Mtdna in Peripheral Blood Mononuclear Cells in HIV-Infected Patients

  2005cites this paper
• Effects of of didanosine-related depletion of mtDNA in human T lymphocytes.

  2005cites this paper
• Toxicité mitochondriale hépatique associée au traitement par les antirétroviraux : Pathologie mitochondriales

  2005cites this paper
• Efectes de la infecció per VIH i dels fàrmacs antiretrovirals envers el mitocondri: les cèl.lules mononuclears de sang perifèrica com a model d'estudi

  2005cites this paper
• Involvement of Apoptosis in complications of HIV and its treatment

  2005cites this paper
• Mitochondrial Studies in Haart-Related Lipodystrophy: From Experimental Hypothesis to Clinical Findings

  2005cites this paper
• Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV‐infected patients on highly active antiretroviral therapy

  2005cites this paper
• Mitochondrial Toxicity of Nucleoside Analogues in Primary Human Lymphocytes

  2005cites this paper
• Evidence From Clinical Experience and Experiments In Vitro and In Vivo

  2004cites this paper
• Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?

  2004cites this paper
• Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.

  2004cites this paper
• Complications Associated with Nrti Therapy: Update on Clinical Features and Possible Pathogenic Mechanisms

  2004cites this paper
• Development of a quantitative PCR (TaqMan) assay for relative mitochondrial DNA copy number and the common mitochondrial DNA deletion in the rat

  2004cites this paper
• Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals.

  2004cites this paper
• Upregulatory Mechanisms Compensate for Mitochondrial DNA Depletion in Asymptomatic Individuals Receiving Stavudine Plus Didanosine

  2004cites this paper
• Platelets, a typical source of error in real-time PCR quantification of mitochondrial DNA content in human peripheral blood cells.

  2004cites this paper
• Update on HIV Lipodystrophy

  2004cites this paper